The biology of a chronic obstructive pulmonary disease exacerbation

被引:27
作者
Hurst, John R. [1 ]
Wedzicha, Jadwiga A. [1 ]
机构
[1] UCL Royal Free Hosp, Royal Free & Univ Coll Med Sch, Acad Unit Resp Unit, London NW3 2PF, England
关键词
D O I
10.1016/j.ccm.2007.05.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Much of the morbidity and mortality in chronic obstructive pulmonary disease relates to symptomatic deteriorations in respiratory health termed exacerbations. Exacerbations also are associated with changes in lung function and both airway and systemic inflammation. The most common causes of exacerbation are micro-organisms: respiratory viruses such as rhinovirus, and various bacterial species. This article reviews and discusses current understanding of the biology of exacerbations, considering the definition, epidemiology, etiology, and the nature and evolution of the changes in symptoms, lung function, and inflammation that characterize these important events.
引用
收藏
页码:525 / +
页数:13
相关论文
共 59 条
[1]   Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease [J].
Aaron, SD ;
Vandemheen, KL ;
Hebert, P ;
Dales, R ;
Stiell, IG ;
Ahuja, J ;
Dickinson, G ;
Brison, R ;
Rowe, BH ;
Dreyer, J ;
Yetisir, E ;
Cass, D ;
Wells, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2618-2625
[2]   Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: Results from the APHEA project [J].
Anderson, HR ;
Spix, C ;
Medina, S ;
Schouten, JP ;
Castellsague, J ;
Rossi, G ;
Zmirou, D ;
Touloumi, G ;
Wojtyniak, B ;
Ponka, A ;
Bacharova, L ;
Schwartz, J ;
Katsouyanni, K .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (05) :1064-1071
[3]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[4]   EFFECTS OF THE ADMINISTRATION OF O2 ON VENTILATION AND BLOOD-GASES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE DURING ACUTE RESPIRATORY-FAILURE [J].
AUBIER, M ;
MURCIANO, D ;
MILICEMILI, J ;
TOUATY, E ;
DAGHFOUS, J ;
PARIENTE, R ;
DERENNE, JP .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1980, 122 (05) :747-754
[5]   Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease [J].
Barbera, JA ;
Roca, J ;
Ferrer, A ;
Felez, MA ;
Diaz, O ;
Roger, N ;
RodriguezRoisin, R .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (06) :1285-1291
[6]   Prevention of ventilator-associated pneumonia by oral decontamination - A prospective, randomized, double-blind, placebo-controlled study [J].
Bergmans, DCJJ ;
Bonten, MJM ;
Gaillard, CA ;
Paling, JC ;
van der Geest, S ;
van Tiel, FH ;
Beysens, AJ ;
de Leeuw, PW ;
Stobberingh, EE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (03) :382-388
[7]   Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations [J].
Bhowmik, A ;
Seemungal, TAR ;
Sapsford, RJ ;
Wedzicha, JA .
THORAX, 2000, 55 (02) :114-120
[8]   Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure [J].
Chu, CM ;
Chan, VL ;
Lin, AWN ;
Wong, IWY ;
Leung, WS ;
Lai, CKW .
THORAX, 2004, 59 (12) :1020-1025
[9]   Outcomes following acute exacerbation of severe chronic obstructive lung disease [J].
Connors, AF ;
Dawson, NV ;
Thomas, C ;
Harrell, FE ;
Desbiens, N ;
Fulkerson, WJ ;
Kussin, P ;
Bellamy, P ;
Goldman, L ;
Knaus, WA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) :959-967
[10]   Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview [J].
Di Stefano, A ;
Caramori, G ;
Ricciardolo, FLM ;
Capelli, A ;
Adcock, IM ;
Donner, CF .
CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (08) :1156-1167